Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M36,715Revenue (TTM) $M6,638Net Margin (%)19.9Altman Z-Score2.2
Enterprise Value $M45,493EPS (TTM) $6.7Operating Margin %22.7Piotroski F-Score5
P/E(ttm)31.1Beneish M-Score-2.6Pre-tax Margin (%)21.4Higher ROA y-yN
Price/Book3.810-y EBITDA Growth Rate %--Quick Ratio0.4Cash flow > EarningsY
Price/Sales6.25-y EBITDA Growth Rate %21.9Current Ratio0.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-42.3ROA % (ttm)7.1Higher Current Ratio y-yY
Dividend Yield %0.4PEG1.3ROE % (ttm)13.8Less Shares Outstanding y-yN
Payout Ratio %12.0Shares Outstanding M197ROIC % (ttm)11.2Gross Margin Increase y-yY

Gurus Latest Trades with SHPG

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SHPGJohn Paulson 2016-03-31 Add0.29%$150.4 - $205
($168.09)
$ 186.0111%Add 3.31%7,071,050
SHPGFirst Eagle Investment 2016-03-31 Add0.02%$150.4 - $205
($168.09)
$ 186.0111%Add 873.75%47,032
SHPGDavid Dreman 2016-03-31 Buy $150.4 - $205
($168.09)
$ 186.0111%New holding154
SHPGKen Fisher 2016-03-31 Add$150.4 - $205
($168.09)
$ 186.0111%Add 16.80%39,657
SHPGLeon Cooperman 2015-12-31 Sold Out -0.19%$188.55 - $231.08
($207.82)
$ 186.01-10%Sold Out0
SHPGJohn Paulson 2015-12-31 Add0.05%$188.55 - $231.08
($207.82)
$ 186.01-10%Add 0.58%6,844,800
SHPGKen Fisher 2015-12-31 Add$188.55 - $231.08
($207.88)
$ 186.01-11%Add 9.30%33,954
SHPGLeon Cooperman 2015-09-30 Reduce-1.74%$197.88 - $268.08
($237.86)
$ 186.01-22%Reduce -90.86%45,367
SHPGJohn Paulson 2015-09-30 Reduce-0.33%$197.88 - $268.08
($237.86)
$ 186.01-22%Reduce -4.09%6,805,200
SHPGKen Fisher 2015-09-30 Add$197.88 - $268.08
($237.86)
$ 186.01-22%Add 54.08%31,064
SHPGJohn Paulson 2015-06-30 Reduce-1.55%$226.9 - $260.15
($247.87)
$ 186.01-25%Reduce -14.81%7,095,100
SHPGFirst Eagle Investment 2015-06-30 Reduce-0.17%$226.9 - $260.15
($247.87)
$ 186.01-25%Reduce -98.36%4,830
SHPGLeon Cooperman 2015-06-30 Reduce-0.02%$226.9 - $260.15
($247.87)
$ 186.01-25%Reduce -0.80%496,192
SHPGKen Fisher 2015-06-30 Add$226.9 - $260.15
($247.87)
$ 186.01-25%Add 36.31%20,161
SHPGFirst Eagle Investment 2015-03-31 Add0.12%$205.66 - $253.64
($229.81)
$ 186.01-19%Add 254.93%294,539
SHPGLeon Cooperman 2015-03-31 Add0.1%$205.66 - $253.64
($229.81)
$ 186.01-19%Add 5.70%500,192
SHPGMario Gabelli 2015-03-31 Sold Out -0.018%$205.66 - $253.64
($229.81)
$ 186.01-19%Sold Out0
SHPGKen Fisher 2015-03-31 Add$205.66 - $253.64
($229.81)
$ 186.01-19%Add 1.35%14,791
SHPGLeon Cooperman 2014-12-31 Buy 1.7%$170.49 - $262.71
($211.39)
$ 186.01-12%New holding473,237
SHPGJohn Paulson 2014-12-31 Reduce-0.77%$170.49 - $262.71
($211.41)
$ 186.01-12%Reduce -7.93%8,328,304
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SHPG is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SHPG: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about SHPG:

News about SHPG:

Articles On GuruFocus.com
Tweedy Browne Fund 4th Quarter Commentary Jan 27 2016 
John Paulson Sells Stake in Broadcom, Cuts Cablevision Holding Nov 18 2015 
Undervalued Baxalta Shares Target of Acquisition by Shire Plc Aug 05 2015 
Manning & Napier's Top 5 New Stock Buys of Q2 Jul 09 2015 
Manning & Napier Invests in Stake in Baidu Jul 08 2015 
Invesco European Growth Fund Parts With Two Stakes Jul 01 2015 
Andreas Halvorsen Increases Stake in Esperion Therapeutics Jun 29 2015 
Smart Guru John Paulson Bullish on Actavis Jun 18 2015 
8 Top Healthcare Stocks to Watch May 13 2015 
John Paulson's Stocks Trading at Low P/E May 04 2015 

More From Other Websites
SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits Jul 01 2016
3 growth stocks still worth buying: Shire plc, Smith & Nephew plc and Coca Cola HBC AG Jul 01 2016
Total Voting Rights Jul 01 2016
Shire Stock Up As Premature Infant Treatment Yields Mixed Results Jun 30 2016
How Is Horizon Pharma Looking on a Price-to-Sales Basis? Jun 30 2016
SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 30 2016
Why ConAgra Foods, Hertz Global, Shire PLC and Two Other Stocks Are on the Move Today Jun 30 2016
Director/PDMR Shareholding Jun 30 2016
Shire stock up 1.3% after premature infant treatment meets secondary endpoints in midstage trial Jun 30 2016
Top-Line Results for Phase 2 Trial of SHP607 Jun 30 2016
Shire Announces Top-Line Results for ... Jun 30 2016
7:01 am Shire announces results of phase 2 study evaluating SHP607, an investigational protein... Jun 30 2016
Shire Announces Top-Line Results for Phase 2 Trial of SHP607 in Extremely Premature Infants Jun 30 2016
UPDATE 1-Shire says ADHD drug meets main goal of study (June 29) Jun 30 2016
[$$] Shire Reports Encouraging Results for ADHD Drug Jun 29 2016
Shire Announces Positive Topline ... Jun 29 2016
Shire says ADHD drug meets main goal of study Jun 29 2016
Shire's stock surges after ADHD drug trial meets key endpoints Jun 29 2016
Shire Announces Positive Topline Results of SHP465 Efficacy and Safety Study in Adults With ADHD Jun 29 2016
Will Lifitegrast Be Approved in 2016? Jun 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)